Al­ler­gan, So­sei halt glob­al de­vel­op­ment for Alzheimer’s drug fol­low­ing tox­ic re­ac­tion in a non-hu­man pri­mate

Al­ler­gan and So­sei have hit the brakes on an in­ter­na­tion­al de­vel­op­ment pro­gram fea­tur­ing a key Alzheimer’s drug fol­low­ing an “un­ex­pect­ed tox­i­col­o­gy find­ing” for one of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER